LI-316b

N/A

Report date: 2023/02/11 20:38:09
NME

Base Information

Drug NameLI-316b
Drug Alias NameLI-316b
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfertility, Male
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnhance Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnhance Biotech
Active IndicationsN/A
Inactive IndicationsInfertility, Male

Other Information

ATC CodeN/A
Related LinksN/A